• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

6-(4-Methyl-1,4-diazepan-1-yl)pyridin-3-amine: A Comprehensive Overview

The compound 6-(4-Methyl-1,4-diazepan-1-yl)pyridin-3-amine, identified by the CAS number 29534973, is a fascinating molecule with significant potential in various fields of chemistry and pharmacology. This compound belongs to the class of pyridine derivatives, which are known for their versatile applications in drug design and material science. The structure of this compound features a pyridine ring substituted with an amino group at the 3-position and a 1,4-diazepane moiety at the 6-position. The presence of the methyl group on the diazepane ring adds further complexity and functional diversity to this molecule.

Recent studies have highlighted the importance of diazepane derivatives in medicinal chemistry due to their ability to form stable hydrogen bonds and their potential as bioisosteres. The integration of a pyridine ring into such a structure enhances the molecule's electronic properties, making it a promising candidate for various biological assays. Researchers have explored its potential as an inhibitor in enzyme-catalyzed reactions, particularly in the context of kinase inhibitors and protease inhibitors.

The synthesis of 6-(4-Methyl-1,4-diazepan-1-yl)pyridin-3-amine involves a multi-step process that combines principles from organic synthesis and heterocyclic chemistry. Key steps include the formation of the diazepane ring through cyclocondensation reactions and subsequent substitution reactions to introduce the pyridine moiety. The use of microwave-assisted synthesis has been reported to significantly reduce reaction times while maintaining high yields, which is a testament to the efficiency of modern synthetic techniques.

In terms of applications, this compound has shown promise in several areas. In pharmacology, it has been evaluated for its ability to modulate cellular signaling pathways, particularly those involving G-protein coupled receptors (GPCRs). Preclinical studies suggest that it may have potential as an antagonist or agonist in specific receptor systems, depending on its structural modifications. Additionally, its role as a building block in more complex molecular architectures has been explored, highlighting its utility in drug discovery programs.

The unique combination of a pyridine ring and a diazepane moiety in this compound provides a platform for further functionalization. Researchers have investigated substituent effects on its physicochemical properties, such as solubility, lipophilicity, and permeability across biological membranes. These studies are crucial for optimizing drug-like properties and ensuring that the compound can be effectively utilized in therapeutic applications.

Recent advancements in computational chemistry have enabled detailed modeling of this compound's interactions with biological targets. Molecular docking studies have provided insights into its binding modes within protein cavities, which is essential for understanding its mechanism of action. Furthermore, quantum mechanical calculations have shed light on its electronic structure and reactivity patterns, aiding in the design of more potent analogs.

In conclusion, 6-(4-Methyl-1,4-diazepan-1-yl)pyridin-3-amie represents a valuable addition to the arsenal of chemical entities being explored for therapeutic purposes. Its unique structure, combined with advancements in synthetic methods and computational tools, positions it as a key player in future research endeavors. As ongoing studies continue to unravel its full potential, this compound is poised to make significant contributions to both academic research and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)